- Cempra Inc CEMP shares dipped 57.4 percent to $2.60 after the company disclosed that it has received a Complete Response Letter from the FDA stating that solithromycin NDAs cannot be approved until safety information and manufacturing facility deficiencies are resolved.
- Interpace Diagnostics Group Inc IDXG shares tumbled 23.9 percent to $5.71. Interpace Diagnostics reported a 1-for-10 reverse split.
- Monster Digital Inc MSDI shares declined 16.4 percent to $1.80.
- Health Insurance Innovations Inc HIIQ shares fell 11.2 percent to $16.20. Health Insurance Innovations shares have surged 206.21 percent over the past 52 weeks, while the S&P 500 index has gained 8.25 percent in the same period.
- Live Ventures Inc LIVE shares dropped 10.6 percent to $24.74 after gaining 6.09 percent on Wednesday.
- Galena Biopharma Inc GALE shares tumbled 10.5 percent to $2.13 after jumping 21.43 percent on Wednesday.
- Dataram Corp DRAM shares declined 8.3 percent to $2.22. Dataram shares have climbed 22.22 percent over the past 52 weeks, while the S&P 500 index has gained 8.25 percent in the same period.
- U.S. Energy Corp. USEG shares dropped 8 percent to $1.27.
- FunctionX Inc FNCX shares fell 7.6 percent to $2.78 after surging 17.53 percent on Wednesday.
- Aptose Biosciences Inc APTO fell 5.7 percent to $1.32 after the company issued an update on APTO-253 development. The company said it found a correctable engineering design incompatibility during the filling process of a fourth 40L batch.
- NVIDIA Corporation NVDA shares declined 4 percent to $104.84 after dropping 6.88 percent on Wednesday.
- Kate Spade & Co KATE fell 2.4 percent to $17.43. Kate Spade shares gained $3.35 on Wednesday on the heels of takeover chatter. However, as of 11:00 a.m. ET, no potential suitor has come forward. As a result, the issue has turned lower on the session.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
